Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Marks

Showing results (231-240 of 248) with videos related to

Pageof 25
Sort By:
Gastroenterology|April 1, 1992
Ulcer recurrence following duodenal ulcer healing with omeprazole, ranitidine, or placebo: a double-blind, multicenter, 6-month study. The Omeprazole Duodenal Ulcer Study GroupD Y Graham, J Colon-Pagan, R S Morse, et al.
Annals of Internal Medicine|March 1, 1984
Low-dose chenodiol to prevent gallstone recurrence after dissolution therapyJ W Marks, S P Lan, R A Baum, et al.
Controlled Clinical Trials|September 1, 1981
Design and methodological considerations in the National Cooperative Gallstone Study: a multicenter clinical trialJ M Lachin, J W Marks, L J Schoenfield, et al.
The Journal of Clinical Endocrinology and Metabolism|October 18, 2012
Relapsing and remitting severe hypoglycemia due to a monoclonal anti-insulin antibody heralding a case of multiple myelomaF Waldron-Lynch, S E Inzucchi, L Menard, et al.
Molecular Cancer Therapeutics|November 18, 2011
Single-chain antibody-based immunotoxins targeting Her2/neu: design optimization and impact of affinity on antitumor efficacy and off-target toxicityYu Cao, James D Marks, Qian Huang, et al.
Neurology|June 16, 2005
New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepineA J Rowan, R E Ramsay, J F Collins, et al.
Pediatric Hematology and Oncology|August 3, 2010
Transfusion and chelation practices in sickle cell disease: a regional perspectiveElliott P Vichinsky, Kwaku Ohene-Frempong, Swee Lay Thein, et al.
Biochemical Pharmacology|June 13, 2012
The therapeutic effects of rGel/BLyS fusion toxin in in vitro and in vivo models of mantle cell lymphomaMi-Ae Lyu, Lan V Pham, Bokyung Sung, et al.
The Journal of Investigative Dermatology|November 30, 2012
The TWEAK receptor Fn14 is a therapeutic target in melanoma: immunotoxins targeting Fn14 receptor for malignant melanoma treatmentHong Zhou, Suhendan Ekmekcioglu, John W Marks, et al.
Current Biology : CB|July 19, 2000
Cdc42 is required for PIP(2)-induced actin polymerization and early development but not for cell viabilityF Chen, L Ma, M C Parrini, et al.
Pageof 25

Showing results (231-240 of 248) with videos related to

Sort By:
Pageof 25
Gastroenterology|April 1, 1992
Ulcer recurrence following duodenal ulcer healing with omeprazole, ranitidine, or placebo: a double-blind, multicenter, 6-month study. The Omeprazole Duodenal Ulcer Study GroupD Y Graham, J Colon-Pagan, R S Morse, et al.
Annals of Internal Medicine|March 1, 1984
Low-dose chenodiol to prevent gallstone recurrence after dissolution therapyJ W Marks, S P Lan, R A Baum, et al.
Controlled Clinical Trials|September 1, 1981
Design and methodological considerations in the National Cooperative Gallstone Study: a multicenter clinical trialJ M Lachin, J W Marks, L J Schoenfield, et al.
The Journal of Clinical Endocrinology and Metabolism|October 18, 2012
Relapsing and remitting severe hypoglycemia due to a monoclonal anti-insulin antibody heralding a case of multiple myelomaF Waldron-Lynch, S E Inzucchi, L Menard, et al.
Molecular Cancer Therapeutics|November 18, 2011
Single-chain antibody-based immunotoxins targeting Her2/neu: design optimization and impact of affinity on antitumor efficacy and off-target toxicityYu Cao, James D Marks, Qian Huang, et al.
Neurology|June 16, 2005
New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepineA J Rowan, R E Ramsay, J F Collins, et al.
Pediatric Hematology and Oncology|August 3, 2010
Transfusion and chelation practices in sickle cell disease: a regional perspectiveElliott P Vichinsky, Kwaku Ohene-Frempong, Swee Lay Thein, et al.
Biochemical Pharmacology|June 13, 2012
The therapeutic effects of rGel/BLyS fusion toxin in in vitro and in vivo models of mantle cell lymphomaMi-Ae Lyu, Lan V Pham, Bokyung Sung, et al.
The Journal of Investigative Dermatology|November 30, 2012
The TWEAK receptor Fn14 is a therapeutic target in melanoma: immunotoxins targeting Fn14 receptor for malignant melanoma treatmentHong Zhou, Suhendan Ekmekcioglu, John W Marks, et al.
Current Biology : CB|July 19, 2000
Cdc42 is required for PIP(2)-induced actin polymerization and early development but not for cell viabilityF Chen, L Ma, M C Parrini, et al.
Pageof 25